Memsel, Inc.
Memsel is a biotechnology research and development company dedicated to enhancing health and combatting infections through advanced phage therapies and targeted delivery systems. The company aims to transform healthcare solutions across human, animal, and plant domains, addressing critical health challenges and antibiotic resistance.
Industries
N/A
Nr. of Employees
small (1-50)
Memsel, Inc.
3500 Camp Bowie Blvd. EAD-116, Fort Worth TX 76107
Products
Sprayable and injectable multicomponent wound-care system
A multicomponent wound-care formulation delivered as sprayable or injectable hydrogel that combines hemostatic action, infection control (phage cocktails, antibiotics, antifungals), analgesic release, and tissue-repair support for trauma and prolonged field care.
Enteric microsphere system for GI-targeted delivery (triple-action formulation)
An enteric-coated microsphere platform for oral delivery that protects bioactives through the stomach and provides controlled release in the small and large intestine; used to combine phage therapies, probiotics, and short-chain fatty acids in a single oral formulation.
Sprayable and injectable multicomponent wound-care system
A multicomponent wound-care formulation delivered as sprayable or injectable hydrogel that combines hemostatic action, infection control (phage cocktails, antibiotics, antifungals), analgesic release, and tissue-repair support for trauma and prolonged field care.
Enteric microsphere system for GI-targeted delivery (triple-action formulation)
An enteric-coated microsphere platform for oral delivery that protects bioactives through the stomach and provides controlled release in the small and large intestine; used to combine phage therapies, probiotics, and short-chain fatty acids in a single oral formulation.
Services
Contract or collaborative research to isolate, characterize, and engineer bacteriophages for therapeutic applications, including design of tailored phage cocktails.
Development of multicomponent formulations, hydrogels, sprayable/injectable systems, and enteric microsphere delivery platforms for site-specific and controlled release of bioactive agents.
Performance comparisons and environmental resilience testing for wound-care and delivery products, including metrics for hemostasis, durability, and temperature/field stability.
Joint research programs with academic medical centers, government entities, and healthcare networks to co-develop and validate therapeutic and delivery solutions.
Contract or collaborative research to isolate, characterize, and engineer bacteriophages for therapeutic applications, including design of tailored phage cocktails.
Development of multicomponent formulations, hydrogels, sprayable/injectable systems, and enteric microsphere delivery platforms for site-specific and controlled release of bioactive agents.
Performance comparisons and environmental resilience testing for wound-care and delivery products, including metrics for hemostasis, durability, and temperature/field stability.
Joint research programs with academic medical centers, government entities, and healthcare networks to co-develop and validate therapeutic and delivery solutions.
Expertise Areas
- Phage therapy development
- Targeted drug delivery
- Wound care therapeutics and hemostasis
- Gut microbiome therapeutics and enteric delivery
Key Technologies
- Bacteriophage isolation and characterization
- High-throughput screening
- Phage engineering and induction
- Phage cocktail formulation